
Sanofi and Medtronic have announced a new tie-up that will see both firms develop new products in the increasingly competitive …

Sanofi and Eli Lilly have announced they are to push ahead with plans to seek regulatory approval for erectile dysfunction …

Sanofi has resubmitted its application for Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis (MS) to the …

Sanofi UK and Ireland’s managing director Steve Oldfield has been elected as chair of the European Medicines Group (EMG). Oldfield …

Sanofi has hired Dr Anne Beal to the newly-created position of chief patient officer. The move to hire such a …
An asthma drug developed by Roche subsidiary Genentech and Novartis has been granted an additional indication to treat chronic hives …
AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …

Sanofi and UCB have announced a new partnership that will see the companies research and develop new medicines together. Specifically, …

GlaxoSmithKline is riding high when it comes to the approval of new medicines but US firm Lilly is falling behind. …

Sanofi is proposing to replace Lord Douro at the French firm with Patrick Kron as its new independent director. Kron …

Sanofi has announced a mixed bag for its full year results as analysts have questioned why its forecasts for the …

A row which has been brewing between Sanofi and Eli Lilly & Company has now erupted with the French manufacturer …

NICE has recommended Genzyme’s multiple sclerosis pill Aubagio for use on the NHS. In final guidance the watchdog said Aubagio …

Sanofi has agreed to produce genetic compounds developed by German biotech Isarna Therepeutics to accelerate their progress to the clinical …